Telix Pharmaceuticals Ltd (ASX: TLX) Share Price and News
Price
Movement
52 Week Range
1 Year Return
() Chart and Price Data
Fundamental Company Figures
Data provided by Morningstar.Telix Pharmaceuticals Ltd (ASX: TLX) Latest News
Why IDP Education, Sandfire, Telix, & Treasury Wine shares are dropping lower
James Mickleboro | November 3, 2020 3:36pm
Why Abacus, Amaysim, CSR, & Telix shares stormed higher today
James Mickleboro | November 2, 2020 4:47pm
Telix (ASX:TLX) share price jumps 30% to an all-time high. Here’s why.
Aaron Teboneras | November 2, 2020 4:44pm
Why Baby Bunting, Northern Star, Oil Search, & Telix shares are storming higher
James Mickleboro | October 6, 2020 11:32am
Telix (ASX:TLX) share price jumps 8% higher on FDA update
James Mickleboro | October 6, 2020 10:42am
Why Atlas Arteria, Cochlear, Telix, & Treasury Wine shares are dropping lower
James Mickleboro | September 25, 2020 11:25am
Why Iron Road, Nuchev, Telix, & Treasury Wine shares are pushing higher today
James Mickleboro | September 24, 2020 11:38am
Telix (ASX:TLX) share price charges higher on FDA update
James Mickleboro | September 24, 2020 10:37am
About Telix Pharmaceuticals Ltd (ASX: TLX)
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer. Geographically, it operates in Australia, the United States, Belgium, and Japan.
Share Price History
Data provided by Morningstar.Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
25 Feb 2021 | $3.93 | $0.02 | 0.51% | 242,516 | $3.91 | $3.98 | $3.90 |
24 Feb 2021 | $3.91 | $-0.09 | -2.25% | 603,037 | $4.00 | $4.05 | $3.91 |
23 Feb 2021 | $4.00 | $-0.10 | -2.44% | 613,575 | $4.07 | $4.08 | $3.94 |
22 Feb 2021 | $4.10 | $-0.03 | -0.73% | 695,833 | $4.12 | $4.15 | $4.05 |
19 Feb 2021 | $4.13 | $0.00 | 0.00% | 523,224 | $4.18 | $4.22 | $4.13 |
18 Feb 2021 | $4.13 | $-0.04 | -0.96% | 254,991 | $4.22 | $4.22 | $4.12 |
17 Feb 2021 | $4.17 | $0.02 | 0.48% | 288,552 | $4.26 | $4.26 | $4.07 |
16 Feb 2021 | $4.15 | $0.03 | 0.73% | 381,154 | $4.15 | $4.31 | $4.06 |
15 Feb 2021 | $4.12 | $-0.03 | -0.72% | 825,704 | $4.24 | $4.37 | $4.12 |
12 Feb 2021 | $4.15 | $0.05 | 1.22% | 342,456 | $4.19 | $4.23 | $4.15 |
11 Feb 2021 | $4.10 | $-0.20 | -4.65% | 467,247 | $4.30 | $4.35 | $4.06 |
10 Feb 2021 | $4.30 | $-0.10 | -2.27% | 337,374 | $4.45 | $4.49 | $4.28 |
09 Feb 2021 | $4.40 | $0.03 | 0.69% | 372,990 | $4.39 | $4.47 | $4.31 |
08 Feb 2021 | $4.37 | $0.18 | 4.30% | 548,097 | $4.20 | $4.42 | $4.17 |
05 Feb 2021 | $4.19 | $0.23 | 5.81% | 527,308 | $4.06 | $4.36 | $4.04 |
04 Feb 2021 | $3.96 | $-0.28 | -6.60% | 431,625 | $4.20 | $4.24 | $3.96 |
03 Feb 2021 | $4.24 | $0.12 | 2.91% | 663,650 | $4.12 | $4.25 | $4.02 |
02 Feb 2021 | $4.12 | $0.24 | 6.19% | 481,226 | $4.02 | $4.17 | $3.97 |
01 Feb 2021 | $3.88 | $-0.05 | -1.27% | 1,139,766 | $3.86 | $3.95 | $3.66 |
29 Jan 2021 | $3.93 | $-0.10 | -2.48% | 466,190 | $4.05 | $4.16 | $3.91 |
28 Jan 2021 | $4.03 | $-0.27 | -6.28% | 906,848 | $4.11 | $4.14 | $3.88 |
27 Jan 2021 | $4.30 | $-0.06 | -1.38% | 841,662 | $4.42 | $4.42 | $4.00 |
Director Transactions
Data provided by Morningstar.Directors & Management
Data provided by Morningstar.Top Share Holders
Data provided by Morningstar.Name | Shares | Capital |
---|---|---|
HSBC Custody Nominees (Australia) Limited | 32,489,522 | 12.83% |
Elk River Holdings Pty Ltd | 24,675,000 | 9.74% |
Gnosis Verwaltungsgesellschaftm B H | 24,675,000 | 9.74% |
BNP Paribas Noms Pty Ltd | 9,406,521 | 3.71% |
Dale Ltd | 7,995,600 | 3.16% |
J P Morgan Nominees Australia Pty Limited | 7,515,730 | 2.97% |
The Oncidium Foundation | 6,719,898 | 2.65% |
Citicorp Nominees Pty Limited | 4,841,331 | 1.91% |
Uv Cap Gmbh & Co Kg | 4,700,000 | 1.86% |
UBS Nominees Pty Ltd | 4,277,983 | 1.69% |
Jean-Marc Le Doussal | 3,901,554 | 1.54% |
BNP Paribas Nominees Pty Ltd | 3,845,417 | 1.52% |
HSBC Custody Nominees (Australia) Limited A/C 2 | 3,425,710 | 1.35% |
Uv-Cap Gmbh & Co | 3,075,000 | 1.21% |
National Nominees Limited | 2,941,405 | 1.16% |
Remora Capital | 2,613,163 | 1.03% |
Ilusa Sprl | 2,558,138 | 1.01% |
Yelwac Pty Ltd | 2,381,804 | 0.94% |
Cyclotek Pty Ltd | 2,350,000 | 0.93% |
Sargon Ct Pty Ltd | 2,242,500 | 0.89% |
Man Holdings Pty Ltd | 2,238,750 | 0.88% |